Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_assertion type Assertion NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_head.
- NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_assertion description "[Antibody-based assays for hCE1 and AFP were used to test both biomarkers with respect to diagnostic efficiency, Youden's index and the area under the curve (AUC) through receiver operating characteristic (ROC) analysis in plasma from 208 patients with HCC (n=57), liver cirrhosis (n=27), chronic hepatitis (n=37), cholangiocarcinoma (n=22), gastric cancer (n=31) and pancreatic cancer (n=34), along with 52 healthy donors (HDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_provenance.
- NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_assertion evidence source_evidence_literature NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_provenance.
- NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_assertion SIO_000772 23319432 NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_provenance.
- NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_assertion wasDerivedFrom befree-20150227 NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_provenance.
- NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_assertion wasGeneratedBy ECO_0000203 NP227691.RAE-WWjiLu_Q9N-iUwlI9-TtMbrxjSK8ofJsUM2GsCyjs130_provenance.